智通财经APP讯，康为世纪(688426.SH)公告，公司全资子公司江苏健为诊断科技有限公司(简称“健为诊断”)自主研发的九项呼吸道病原体核酸检测试剂盒(荧光PCR法)收到国家药品监督管理局颁发的III类《医疗器械注册证(体外诊断试剂)》。
据公告所示，健为诊断此次自主研发的呼吸道病原体检测产品“九项呼吸道病原体核酸检测试剂盒(荧光PCR法)”是一款基于荧光定量PCR方法，采用了先进的冻干技术，在体外定性检测人咽拭子样本中的甲型流感病毒(FluA)、乙型流感病毒(FluB)、呼吸道合胞病毒(RSV)、人鼻病毒(HRV)、肺炎支原体(MP)、腺病毒(ADV)、副流感病毒Ⅰ型(PIVⅠ)、副流感病毒Ⅱ型(PIVⅡ)及副流感病毒Ⅲ型(PIVⅢ)核酸的产品。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.